Unknown v. S.K.Maingi

Patent infringement battles are often fought over the science, the claims, and the evidence of copying. But sometimes, a case collapses before any of that is even examined, because the plaintiff chose the wrong battlefield. This is precisely what happened when a patent holder tried to enforce Indian Patent No. 196774, covering Erlotinib Hydrochloride, in a court that simply had no business hearing the case. For founders and IP professionals, this case is a stark reminder that where you file matters just as much as what you file.

The dispute centered on Indian Patent No. 196774, which protects Erlotinib Hydrochloride, a pharmaceutical compound used in cancer treatment. The plaintiffs, holding rights to this patent, alleged that the defendant, S.K. Maingi, was infringing their intellectual property. Seeking both a permanent injunction to stop the alleged infringement and damages to compensate for the harm caused, the plaintiffs brought their suit before the Madras High Court. However, a fundamental procedural question lurked beneath the surface: did this court actually have the authority to entertain the case?

The legal friction in this case was not about whether the patent was valid or whether infringement had occurred. Instead, the battleground was territorial jurisdiction. The plaintiffs needed to demonstrate that a substantial part of the cause of action had arisen within the jurisdiction of the Madras High Court. The defendant challenged this foundation, pointing out that the plaintiff was not a resident of Delhi and that the alleged infringing activities, specifically sales conducted through C&F (Carrying and Forwarding) agents, were isolated incidents. The argument was clear: a few scattered transactions by intermediaries do not create the kind of meaningful, ongoing commercial activity within a territory that would justify dragging a defendant into a particular court's jurisdiction.

The Madras High Court ruled in favor of the defendant, finding that the plaintiffs had failed to establish the necessary territorial jurisdiction. The court held that isolated sales by C&F agents were insufficient to constitute a substantial cause of action arising within its jurisdiction. Without this foundational requirement met, the infringement suit could not be maintained in that forum. The case was effectively dismissed on jurisdictional grounds, leaving the substantive questions about the patent and alleged infringement entirely unresolved.

For founders, startup leaders, and IP professionals, this case delivers a critical lesson: before rushing to file an infringement suit, rigorously evaluate whether your chosen court actually has territorial jurisdiction over the dispute. A few isolated sales or the presence of a C&F agent in a region is not enough. The cause of action must substantially arise within that court's territory, meaning there must be meaningful, sustained commercial activity or clear infringing acts tied to that location. Choosing the wrong forum can waste years of litigation effort and leave your patent rights unprotected. Always map your enforcement strategy to where the real, substantial business of the alleged infringer is happening.